

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.85835600 |
| 2 | viral transcription (GO:0019083) | 5.04637791 |
| 3 | male meiosis I (GO:0007141) | 5.04116455 |
| 4 | DNA deamination (GO:0045006) | 4.97186506 |
| 5 | translational termination (GO:0006415) | 4.89517871 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 4.77876548 |
| 7 | piRNA metabolic process (GO:0034587) | 4.67583157 |
| 8 | translational elongation (GO:0006414) | 4.52744055 |
| 9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.50229237 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.39878738 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.33623753 |
| 12 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.32311071 |
| 13 | meiosis I (GO:0007127) | 4.30410203 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 4.29057171 |
| 15 | protein targeting to ER (GO:0045047) | 4.24222101 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 4.22862708 |
| 17 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.14916397 |
| 18 | negative regulation of RNA splicing (GO:0033119) | 4.13282098 |
| 19 | DNA strand elongation (GO:0022616) | 4.10299250 |
| 20 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.06107685 |
| 21 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.05577507 |
| 22 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.04055089 |
| 23 | protein localization to endoplasmic reticulum (GO:0070972) | 3.96985914 |
| 24 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.96213215 |
| 25 | synapsis (GO:0007129) | 3.94970208 |
| 26 | translational initiation (GO:0006413) | 3.93189157 |
| 27 | viral life cycle (GO:0019058) | 3.92464544 |
| 28 | metallo-sulfur cluster assembly (GO:0031163) | 3.75969951 |
| 29 | iron-sulfur cluster assembly (GO:0016226) | 3.75969951 |
| 30 | telomere maintenance via recombination (GO:0000722) | 3.72609160 |
| 31 | DNA methylation involved in gamete generation (GO:0043046) | 3.72280351 |
| 32 | formation of translation preinitiation complex (GO:0001731) | 3.70504084 |
| 33 | ribosomal small subunit biogenesis (GO:0042274) | 3.68496991 |
| 34 | cellular protein complex disassembly (GO:0043624) | 3.68068731 |
| 35 | base-excision repair, AP site formation (GO:0006285) | 3.65409431 |
| 36 | DNA replication initiation (GO:0006270) | 3.56797621 |
| 37 | DNA synthesis involved in DNA repair (GO:0000731) | 3.49906866 |
| 38 | mitotic recombination (GO:0006312) | 3.49846400 |
| 39 | protein complex disassembly (GO:0043241) | 3.45901568 |
| 40 | meiotic nuclear division (GO:0007126) | 3.39544830 |
| 41 | chromosome organization involved in meiosis (GO:0070192) | 3.37341831 |
| 42 | negative regulation of mRNA processing (GO:0050686) | 3.34440793 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.33179139 |
| 44 | male meiosis (GO:0007140) | 3.31673615 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.27621033 |
| 46 | meiotic chromosome segregation (GO:0045132) | 3.26928422 |
| 47 | macromolecular complex disassembly (GO:0032984) | 3.26338044 |
| 48 | telomere maintenance via telomere lengthening (GO:0010833) | 3.25881360 |
| 49 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.23678212 |
| 50 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.19874218 |
| 51 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.19874218 |
| 52 | translesion synthesis (GO:0019985) | 3.19315214 |
| 53 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.13168776 |
| 54 | translation (GO:0006412) | 3.11684502 |
| 55 | ribosomal large subunit biogenesis (GO:0042273) | 3.11570372 |
| 56 | regulation of mitochondrial translation (GO:0070129) | 3.11255505 |
| 57 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.11104213 |
| 58 | pseudouridine synthesis (GO:0001522) | 3.09167899 |
| 59 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.06904112 |
| 60 | DNA replication checkpoint (GO:0000076) | 3.06791911 |
| 61 | mRNA catabolic process (GO:0006402) | 3.05775501 |
| 62 | negative regulation of mRNA metabolic process (GO:1903312) | 3.03966906 |
| 63 | reciprocal DNA recombination (GO:0035825) | 3.02627821 |
| 64 | reciprocal meiotic recombination (GO:0007131) | 3.02627821 |
| 65 | RNA catabolic process (GO:0006401) | 2.98879137 |
| 66 | viral mRNA export from host cell nucleus (GO:0046784) | 2.97992434 |
| 67 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.96959765 |
| 68 | IMP biosynthetic process (GO:0006188) | 2.95575113 |
| 69 | sister chromatid cohesion (GO:0007062) | 2.95295041 |
| 70 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.92561597 |
| 71 | spliceosomal complex assembly (GO:0000245) | 2.92347080 |
| 72 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.91687365 |
| 73 | mRNA splicing, via spliceosome (GO:0000398) | 2.91687365 |
| 74 | deoxyribonucleotide catabolic process (GO:0009264) | 2.91217972 |
| 75 | RNA splicing, via transesterification reactions (GO:0000375) | 2.89814466 |
| 76 | cellular response to interferon-beta (GO:0035458) | 2.89810942 |
| 77 | termination of RNA polymerase II transcription (GO:0006369) | 2.87400333 |
| 78 | histone H2A acetylation (GO:0043968) | 2.86904085 |
| 79 | spliceosomal snRNP assembly (GO:0000387) | 2.85584134 |
| 80 | ribosome biogenesis (GO:0042254) | 2.85234630 |
| 81 | regulation of protein heterodimerization activity (GO:0043497) | 2.85219912 |
| 82 | synaptonemal complex assembly (GO:0007130) | 2.84083755 |
| 83 | proteasome assembly (GO:0043248) | 2.83245104 |
| 84 | protein targeting to membrane (GO:0006612) | 2.80625775 |
| 85 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.80257030 |
| 86 | IMP metabolic process (GO:0046040) | 2.79270801 |
| 87 | protein autoprocessing (GO:0016540) | 2.79094074 |
| 88 | tRNA modification (GO:0006400) | 2.77895927 |
| 89 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.77366813 |
| 90 | base-excision repair (GO:0006284) | 2.74623337 |
| 91 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73584741 |
| 92 | DNA duplex unwinding (GO:0032508) | 2.72643521 |
| 93 | mannosylation (GO:0097502) | 2.72198528 |
| 94 | positive regulation of prostaglandin secretion (GO:0032308) | 2.71280130 |
| 95 | deoxyribose phosphate catabolic process (GO:0046386) | 2.70746158 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70151764 |
| 97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70151764 |
| 98 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.69978960 |
| 99 | DNA geometric change (GO:0032392) | 2.69838123 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69693719 |
| 101 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.68790354 |
| 102 | mitotic nuclear envelope disassembly (GO:0007077) | 2.68550379 |
| 103 | nucleobase biosynthetic process (GO:0046112) | 2.68093463 |
| 104 | postreplication repair (GO:0006301) | 2.67557727 |
| 105 | synaptonemal complex organization (GO:0070193) | 2.66955236 |
| 106 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.65653196 |
| 107 | mitochondrial DNA replication (GO:0006264) | 2.65485197 |
| 108 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.65013875 |
| 109 | tRNA methylation (GO:0030488) | 2.63144252 |
| 110 | telomere organization (GO:0032200) | 2.60753523 |
| 111 | telomere maintenance (GO:0000723) | 2.60722627 |
| 112 | rRNA processing (GO:0006364) | 2.60239949 |
| 113 | dosage compensation (GO:0007549) | 2.56707302 |
| 114 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.56186180 |
| 115 | DNA replication-independent nucleosome organization (GO:0034724) | 2.55988361 |
| 116 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.55988361 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.55704842 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.55704842 |
| 119 | NADH dehydrogenase complex assembly (GO:0010257) | 2.55704842 |
| 120 | regulation of chromatin binding (GO:0035561) | 2.55308422 |
| 121 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.54576999 |
| 122 | T cell apoptotic process (GO:0070231) | 2.53578474 |
| 123 | pyrimidine dimer repair (GO:0006290) | 2.52624046 |
| 124 | protein K6-linked ubiquitination (GO:0085020) | 2.51356117 |
| 125 | regulation of translational fidelity (GO:0006450) | 2.49326746 |
| 126 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48990432 |
| 127 | rRNA metabolic process (GO:0016072) | 2.48879331 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.48529590 |
| 129 | tRNA aminoacylation for protein translation (GO:0006418) | 2.48357336 |
| 130 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.48189299 |
| 131 | ncRNA 3-end processing (GO:0043628) | 2.48014559 |
| 132 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.47422151 |
| 133 | nucleoside salvage (GO:0043174) | 2.47199124 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47124077 |
| 135 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.46785550 |
| 136 | positive regulation of mitochondrial fission (GO:0090141) | 2.46471561 |
| 137 | membrane disassembly (GO:0030397) | 2.46450592 |
| 138 | nuclear envelope disassembly (GO:0051081) | 2.46450592 |
| 139 | purine-containing compound salvage (GO:0043101) | 2.45910426 |
| 140 | amino acid activation (GO:0043038) | 2.45069994 |
| 141 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.44829310 |
| 142 | microtubule nucleation (GO:0007020) | 2.43662085 |
| 143 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43648867 |
| 144 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.40730118 |
| 145 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.38557142 |
| 146 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.38557142 |
| 147 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.38557142 |
| 148 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.37540578 |
| 149 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.37540578 |
| 150 | meiotic cell cycle process (GO:1903046) | 2.37081260 |
| 151 | DNA double-strand break processing (GO:0000729) | 2.36316490 |
| 152 | DNA modification (GO:0006304) | 2.33782085 |
| 153 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.33084204 |
| 154 | positive regulation of T cell cytokine production (GO:0002726) | 2.32457977 |
| 155 | positive regulation of granulocyte differentiation (GO:0030854) | 2.32320671 |
| 156 | positive T cell selection (GO:0043368) | 2.32050904 |
| 157 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.31080864 |
| 158 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.31080864 |
| 159 | nucleotide salvage (GO:0043173) | 2.30416261 |
| 160 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.29913287 |
| 161 | tRNA processing (GO:0008033) | 2.29052078 |
| 162 | ubiquinone biosynthetic process (GO:0006744) | 2.28644435 |
| 163 | protein complex biogenesis (GO:0070271) | 2.27385964 |
| 164 | regulation of histone H3-K9 methylation (GO:0051570) | 2.27149047 |
| 165 | chromatin remodeling at centromere (GO:0031055) | 2.27060085 |
| 166 | CENP-A containing nucleosome assembly (GO:0034080) | 2.26181774 |
| 167 | NIK/NF-kappaB signaling (GO:0038061) | 2.25825209 |
| 168 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.25652013 |
| 169 | cytochrome complex assembly (GO:0017004) | 2.25584914 |
| 170 | mismatch repair (GO:0006298) | 2.25099649 |
| 171 | negative regulation of B cell apoptotic process (GO:0002903) | 2.23832962 |
| 172 | positive regulation of response to oxidative stress (GO:1902884) | 2.23473891 |
| 173 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.23473891 |
| 174 | protein K11-linked deubiquitination (GO:0035871) | 2.23097843 |
| 175 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.21426648 |
| 176 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.20923540 |
| 177 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.20268812 |
| 178 | methionine metabolic process (GO:0006555) | 2.19599548 |
| 179 | regulation of B cell differentiation (GO:0045577) | 2.18962308 |
| 180 | RNA modification (GO:0009451) | 2.18806858 |
| 181 | deoxyribose phosphate metabolic process (GO:0019692) | 2.16314121 |
| 182 | peptidyl-histidine modification (GO:0018202) | 2.16309482 |
| 183 | regulation of immunoglobulin secretion (GO:0051023) | 2.16118378 |
| 184 | GPI anchor metabolic process (GO:0006505) | 2.16108295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.52979063 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.00811794 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.79527822 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.11818432 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.58477292 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.55458860 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.53638906 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.50641104 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.46303267 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.44790425 |
| 11 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.40042702 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.37038934 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.35061075 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31939298 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.31289965 |
| 16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27311374 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26654277 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.21302228 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20396409 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.19068369 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18963925 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.18142409 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.14131985 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.12994415 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12985662 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09286155 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98740263 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.98299318 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97936581 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.96910754 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.94911102 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84366083 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.83459902 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.80044423 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78060998 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77157493 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75580951 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74788201 |
| 39 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.72334179 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71540102 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69481328 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.69344035 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69249211 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65790250 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64655079 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63491259 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62471099 |
| 48 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.61506345 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57499660 |
| 50 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57451088 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.57066273 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56895721 |
| 53 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.53672525 |
| 54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51545987 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49595741 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48994117 |
| 57 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48284289 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46015259 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44892728 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43679628 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43262134 |
| 62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42967938 |
| 63 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42463263 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37173083 |
| 65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36890952 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36102293 |
| 67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.35493087 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33228761 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32807887 |
| 70 | MAF_26560356_Chip-Seq_TH1_Human | 1.32654055 |
| 71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.32272337 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32245236 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32017347 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31768338 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31758726 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30993705 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30668409 |
| 78 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29579382 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27916175 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.26558567 |
| 81 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26442601 |
| 82 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26049016 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24961777 |
| 84 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24415413 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24275151 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23457018 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22510403 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22338575 |
| 89 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.22117197 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20229316 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18791079 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17949327 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17921109 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17575752 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16980428 |
| 96 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16061464 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15562254 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15051458 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14922292 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14736349 |
| 101 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13863449 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13475814 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12504320 |
| 104 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12335841 |
| 105 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11221141 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.10869026 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10418209 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 1.09357337 |
| 109 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08009533 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07896998 |
| 111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06616722 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05712514 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05267603 |
| 114 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.05254867 |
| 115 | MYB_26560356_Chip-Seq_TH2_Human | 1.04980423 |
| 116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04119352 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.02522304 |
| 118 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01424816 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01359520 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99672920 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98751156 |
| 122 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96765086 |
| 123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96619716 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96297046 |
| 125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96007605 |
| 126 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95567161 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94467545 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93730426 |
| 129 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93596289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.38656240 |
| 2 | MP0003646_muscle_fatigue | 2.97250945 |
| 3 | MP0010094_abnormal_chromosome_stability | 2.92155409 |
| 4 | MP0000372_irregular_coat_pigmentation | 2.88857632 |
| 5 | MP0008877_abnormal_DNA_methylation | 2.85047668 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 2.82606346 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.69970304 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.58949180 |
| 9 | MP0003077_abnormal_cell_cycle | 2.56829654 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.25785542 |
| 11 | MP0002822_catalepsy | 2.24857183 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.23755196 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.20165028 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.18947658 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.11691754 |
| 16 | MP0000685_abnormal_immune_system | 2.11254849 |
| 17 | MP0008995_early_reproductive_senescence | 2.11131837 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.09551005 |
| 19 | MP0008058_abnormal_DNA_repair | 2.05046996 |
| 20 | MP0000490_abnormal_crypts_of | 2.02388334 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.01110354 |
| 22 | MP0002398_abnormal_bone_marrow | 1.87733233 |
| 23 | MP0002102_abnormal_ear_morphology | 1.84640272 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.80644059 |
| 25 | MP0000703_abnormal_thymus_morphology | 1.75196307 |
| 26 | MP0001730_embryonic_growth_arrest | 1.71499564 |
| 27 | MP0006054_spinal_hemorrhage | 1.71378003 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.68852451 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.68852451 |
| 30 | MP0008057_abnormal_DNA_replication | 1.67856750 |
| 31 | MP0002722_abnormal_immune_system | 1.66858517 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.61059164 |
| 33 | MP0000350_abnormal_cell_proliferation | 1.58195181 |
| 34 | MP0002210_abnormal_sex_determination | 1.57021708 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.55907474 |
| 36 | MP0005671_abnormal_response_to | 1.53790070 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.53152834 |
| 38 | MP0004147_increased_porphyrin_level | 1.51114687 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.50570831 |
| 40 | MP0002006_tumorigenesis | 1.49197309 |
| 41 | MP0001873_stomach_inflammation | 1.47847775 |
| 42 | MP0002019_abnormal_tumor_incidence | 1.47533765 |
| 43 | MP0009785_altered_susceptibility_to | 1.47480888 |
| 44 | MP0001929_abnormal_gametogenesis | 1.46499544 |
| 45 | MP0001800_abnormal_humoral_immune | 1.46224754 |
| 46 | MP0002429_abnormal_blood_cell | 1.44343539 |
| 47 | MP0009764_decreased_sensitivity_to | 1.42831277 |
| 48 | MP0000716_abnormal_immune_system | 1.38449046 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.32696170 |
| 50 | MP0001853_heart_inflammation | 1.32159143 |
| 51 | MP0004142_abnormal_muscle_tone | 1.31688343 |
| 52 | MP0005389_reproductive_system_phenotype | 1.31116099 |
| 53 | MP0001849_ear_inflammation | 1.31094553 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.30917870 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.30083531 |
| 56 | MP0001819_abnormal_immune_cell | 1.29621479 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.29467210 |
| 58 | MP0002080_prenatal_lethality | 1.28657568 |
| 59 | MP0008932_abnormal_embryonic_tissue | 1.28180539 |
| 60 | MP0000313_abnormal_cell_death | 1.26921295 |
| 61 | MP0004197_abnormal_fetal_growth/weight/ | 1.24258767 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.21493730 |
| 63 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21005091 |
| 64 | MP0003698_abnormal_male_reproductive | 1.20240781 |
| 65 | MP0001919_abnormal_reproductive_system | 1.20014140 |
| 66 | MP0002723_abnormal_immune_serum | 1.19985865 |
| 67 | MP0002160_abnormal_reproductive_system | 1.18824522 |
| 68 | MP0003786_premature_aging | 1.18726496 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.18605028 |
| 70 | MP0001145_abnormal_male_reproductive | 1.18279597 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.18215017 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.15649334 |
| 73 | MP0001697_abnormal_embryo_size | 1.13963672 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.13237579 |
| 75 | MP0003866_abnormal_defecation | 1.12353578 |
| 76 | MP0003984_embryonic_growth_retardation | 1.12199391 |
| 77 | MP0005266_abnormal_metabolism | 1.12172967 |
| 78 | MP0003136_yellow_coat_color | 1.12076164 |
| 79 | MP0000653_abnormal_sex_gland | 1.09975557 |
| 80 | MP0005025_abnormal_response_to | 1.08497152 |
| 81 | MP0005310_abnormal_salivary_gland | 1.07551617 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 1.07397931 |
| 83 | MP0010307_abnormal_tumor_latency | 1.07397347 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.07161343 |
| 85 | MP0000358_abnormal_cell_content/ | 1.06142928 |
| 86 | MP0005464_abnormal_platelet_physiology | 1.06109495 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 1.05714910 |
| 88 | MP0000858_altered_metastatic_potential | 1.05711569 |
| 89 | MP0005380_embryogenesis_phenotype | 1.05640513 |
| 90 | MP0001672_abnormal_embryogenesis/_devel | 1.05640513 |
| 91 | MP0002163_abnormal_gland_morphology | 1.04370462 |
| 92 | MP0005058_abnormal_lysosome_morphology | 1.00132713 |
| 93 | MP0002419_abnormal_innate_immunity | 0.99688922 |
| 94 | MP0004510_myositis | 0.99575535 |
| 95 | MP0001293_anophthalmia | 0.99169018 |
| 96 | MP0000733_abnormal_muscle_development | 0.99078059 |
| 97 | MP0005000_abnormal_immune_tolerance | 0.98053169 |
| 98 | MP0004947_skin_inflammation | 0.98043902 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.97731495 |
| 100 | MP0001790_abnormal_immune_system | 0.97442961 |
| 101 | MP0005387_immune_system_phenotype | 0.97442961 |
| 102 | MP0003436_decreased_susceptibility_to | 0.96058556 |
| 103 | MP0002086_abnormal_extraembryonic_tissu | 0.95501695 |
| 104 | MP0002132_abnormal_respiratory_system | 0.94791605 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.93691422 |
| 106 | MP0002653_abnormal_ependyma_morphology | 0.92613643 |
| 107 | MP0002405_respiratory_system_inflammati | 0.92583727 |
| 108 | MP0009840_abnormal_foam_cell | 0.92300766 |
| 109 | MP0001188_hyperpigmentation | 0.91774641 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.90531991 |
| 111 | MP0005253_abnormal_eye_physiology | 0.90277676 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.89803152 |
| 113 | MP0000371_diluted_coat_color | 0.89344724 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.88798064 |
| 115 | MP0000598_abnormal_liver_morphology | 0.88648581 |
| 116 | MP0009379_abnormal_foot_pigmentation | 0.88297616 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.87761614 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.87534282 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.87023232 |
| 120 | MP0003123_paternal_imprinting | 0.86476533 |
| 121 | MP0002084_abnormal_developmental_patter | 0.86459814 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.85721858 |
| 123 | MP0001119_abnormal_female_reproductive | 0.85099369 |
| 124 | MP0002085_abnormal_embryonic_tissue | 0.84865013 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.84218683 |
| 126 | MP0000569_abnormal_digit_pigmentation | 0.82024125 |
| 127 | MP0006082_CNS_inflammation | 0.81729852 |
| 128 | MP0006072_abnormal_retinal_apoptosis | 0.81193408 |
| 129 | MP0005647_abnormal_sex_gland | 0.80747535 |
| 130 | MP0002075_abnormal_coat/hair_pigmentati | 0.80739904 |
| 131 | MP0009278_abnormal_bone_marrow | 0.80719631 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.80209917 |
| 133 | MP0003186_abnormal_redox_activity | 0.79191396 |
| 134 | MP0000383_abnormal_hair_follicle | 0.78092326 |
| 135 | MP0009046_muscle_twitch | 0.77606949 |
| 136 | MP0005551_abnormal_eye_electrophysiolog | 0.77527446 |
| 137 | MP0009053_abnormal_anal_canal | 0.76623219 |
| 138 | MP0002095_abnormal_skin_pigmentation | 0.76387308 |
| 139 | MP0000750_abnormal_muscle_regeneration | 0.76292154 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.73673372 |
| 141 | MP0008260_abnormal_autophagy | 0.73530843 |
| 142 | MP0001501_abnormal_sleep_pattern | 0.73466856 |
| 143 | MP0002234_abnormal_pharynx_morphology | 0.72941453 |
| 144 | MP0001764_abnormal_homeostasis | 0.71639712 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.71341035 |
| 146 | MP0001986_abnormal_taste_sensitivity | 0.71022942 |
| 147 | MP0006292_abnormal_olfactory_placode | 0.70355826 |
| 148 | MP0010030_abnormal_orbit_morphology | 0.70016079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.15003399 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.90603995 |
| 3 | Reticulocytopenia (HP:0001896) | 3.98436048 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.65127552 |
| 5 | Thrombocytosis (HP:0001894) | 3.54457104 |
| 6 | Pallor (HP:0000980) | 3.51055474 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.26421510 |
| 8 | Progressive microcephaly (HP:0000253) | 3.22865628 |
| 9 | Stomatitis (HP:0010280) | 3.03192941 |
| 10 | Aplastic anemia (HP:0001915) | 3.02927811 |
| 11 | Hepatic necrosis (HP:0002605) | 2.92461940 |
| 12 | Mitochondrial inheritance (HP:0001427) | 2.85088752 |
| 13 | Increased CSF lactate (HP:0002490) | 2.71417680 |
| 14 | Basal cell carcinoma (HP:0002671) | 2.68819545 |
| 15 | Macrocytic anemia (HP:0001972) | 2.68793431 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 2.67561805 |
| 17 | Selective tooth agenesis (HP:0001592) | 2.67146828 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64721919 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64721919 |
| 20 | Colon cancer (HP:0003003) | 2.63406416 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58967413 |
| 22 | Muscle fiber atrophy (HP:0100295) | 2.57726703 |
| 23 | Amaurosis fugax (HP:0100576) | 2.55347722 |
| 24 | IgM deficiency (HP:0002850) | 2.49832725 |
| 25 | Microretrognathia (HP:0000308) | 2.48146212 |
| 26 | IgG deficiency (HP:0004315) | 2.47845512 |
| 27 | Pancreatic cysts (HP:0001737) | 2.46713832 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 2.45537118 |
| 29 | Chronic otitis media (HP:0000389) | 2.45066283 |
| 30 | B lymphocytopenia (HP:0010976) | 2.42963220 |
| 31 | Abnormality of B cell number (HP:0010975) | 2.42963220 |
| 32 | Tubulointerstitial nephritis (HP:0001970) | 2.39366473 |
| 33 | Progressive muscle weakness (HP:0003323) | 2.36722384 |
| 34 | Optic nerve coloboma (HP:0000588) | 2.36122640 |
| 35 | Microvesicular hepatic steatosis (HP:0001414) | 2.35448836 |
| 36 | Multiple enchondromatosis (HP:0005701) | 2.35004202 |
| 37 | Pustule (HP:0200039) | 2.34629664 |
| 38 | Recurrent viral infections (HP:0004429) | 2.33498880 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.33458191 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32009983 |
| 41 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31424168 |
| 42 | Molar tooth sign on MRI (HP:0002419) | 2.30315173 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 2.30315173 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.28379792 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.27861256 |
| 46 | Albinism (HP:0001022) | 2.27803881 |
| 47 | Petechiae (HP:0000967) | 2.27021289 |
| 48 | Birth length less than 3rd percentile (HP:0003561) | 2.25283092 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25128652 |
| 50 | Oral leukoplakia (HP:0002745) | 2.22147869 |
| 51 | 11 pairs of ribs (HP:0000878) | 2.21070869 |
| 52 | Abnormality of T cell physiology (HP:0011840) | 2.20613377 |
| 53 | Type II lissencephaly (HP:0007260) | 2.19383802 |
| 54 | Opisthotonus (HP:0002179) | 2.16489383 |
| 55 | Abnormality of T cells (HP:0002843) | 2.16207965 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14549207 |
| 57 | Poor head control (HP:0002421) | 2.14196144 |
| 58 | Trismus (HP:0000211) | 2.12070166 |
| 59 | Increased muscle lipid content (HP:0009058) | 2.12045151 |
| 60 | Hyperacusis (HP:0010780) | 2.11864423 |
| 61 | Prominent nose (HP:0000448) | 2.11564332 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.11459020 |
| 63 | Lactic acidosis (HP:0003128) | 2.10821803 |
| 64 | Ependymoma (HP:0002888) | 2.09189797 |
| 65 | Progressive inability to walk (HP:0002505) | 2.06748033 |
| 66 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.06302587 |
| 67 | Nephronophthisis (HP:0000090) | 2.05745246 |
| 68 | High pitched voice (HP:0001620) | 2.05470758 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.05091448 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.05007511 |
| 71 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04860477 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04576912 |
| 73 | Acute encephalopathy (HP:0006846) | 2.02564989 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01911671 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01911671 |
| 76 | Abnormal protein glycosylation (HP:0012346) | 2.01911671 |
| 77 | Abnormal glycosylation (HP:0012345) | 2.01911671 |
| 78 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01752517 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01665139 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01665139 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01665139 |
| 82 | Chronic hepatic failure (HP:0100626) | 2.00860096 |
| 83 | Degeneration of anterior horn cells (HP:0002398) | 2.00548734 |
| 84 | Abnormality of the anterior horn cell (HP:0006802) | 2.00548734 |
| 85 | Absent thumb (HP:0009777) | 2.00428430 |
| 86 | Broad distal phalanx of finger (HP:0009836) | 1.98924636 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98702960 |
| 88 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97374935 |
| 89 | Medulloblastoma (HP:0002885) | 1.95781335 |
| 90 | Lymphopenia (HP:0001888) | 1.95269448 |
| 91 | Lymphoma (HP:0002665) | 1.94597559 |
| 92 | Hypoplasia of the pons (HP:0012110) | 1.94328081 |
| 93 | True hermaphroditism (HP:0010459) | 1.93981682 |
| 94 | Abnormality of the prostate (HP:0008775) | 1.93307971 |
| 95 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93160294 |
| 96 | Encephalitis (HP:0002383) | 1.92489727 |
| 97 | Gastrointestinal inflammation (HP:0004386) | 1.92386088 |
| 98 | Mediastinal lymphadenopathy (HP:0100721) | 1.92278636 |
| 99 | Increased serum ferritin (HP:0003281) | 1.92095615 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 1.91835095 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.91835095 |
| 102 | Volvulus (HP:0002580) | 1.91663517 |
| 103 | Abnormality of the fingertips (HP:0001211) | 1.91477003 |
| 104 | Abnormality of alanine metabolism (HP:0010916) | 1.90037405 |
| 105 | Hyperalaninemia (HP:0003348) | 1.90037405 |
| 106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90037405 |
| 107 | Abnormality of the renal medulla (HP:0100957) | 1.88927464 |
| 108 | Cerebral palsy (HP:0100021) | 1.88873896 |
| 109 | Recurrent bacterial skin infections (HP:0005406) | 1.88718961 |
| 110 | Progressive macrocephaly (HP:0004481) | 1.88428915 |
| 111 | Myelodysplasia (HP:0002863) | 1.87893413 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 1.87357972 |
| 113 | Cellular immunodeficiency (HP:0005374) | 1.87326005 |
| 114 | Abnormality of reticulocytes (HP:0004312) | 1.85726337 |
| 115 | Increased IgM level (HP:0003496) | 1.85708231 |
| 116 | Proximal placement of thumb (HP:0009623) | 1.85369372 |
| 117 | Lissencephaly (HP:0001339) | 1.84920389 |
| 118 | IgA deficiency (HP:0002720) | 1.84415518 |
| 119 | Acute hepatic failure (HP:0006554) | 1.83270164 |
| 120 | Recurrent fungal infections (HP:0002841) | 1.82121019 |
| 121 | Methylmalonic aciduria (HP:0012120) | 1.81574462 |
| 122 | Ocular albinism (HP:0001107) | 1.81016091 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80737327 |
| 124 | Abnormal number of incisors (HP:0011064) | 1.80736398 |
| 125 | Autoimmune thrombocytopenia (HP:0001973) | 1.80670251 |
| 126 | Polydipsia (HP:0001959) | 1.80423526 |
| 127 | Abnormal drinking behavior (HP:0030082) | 1.80423526 |
| 128 | Microcytic anemia (HP:0001935) | 1.80111354 |
| 129 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78915337 |
| 130 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78915337 |
| 131 | Epistaxis (HP:0000421) | 1.78061613 |
| 132 | Cleft eyelid (HP:0000625) | 1.77473074 |
| 133 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.77179343 |
| 134 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75505877 |
| 135 | Abnormal biliary tract physiology (HP:0012439) | 1.74505121 |
| 136 | Bile duct proliferation (HP:0001408) | 1.74505121 |
| 137 | Prostate neoplasm (HP:0100787) | 1.74328752 |
| 138 | Severe global developmental delay (HP:0011344) | 1.74252373 |
| 139 | Cerebral hypomyelination (HP:0006808) | 1.74096587 |
| 140 | Optic disc pallor (HP:0000543) | 1.73509854 |
| 141 | Inability to walk (HP:0002540) | 1.73216448 |
| 142 | Absent speech (HP:0001344) | 1.72258938 |
| 143 | Shoulder girdle muscle weakness (HP:0003547) | 1.71926581 |
| 144 | Lipid accumulation in hepatocytes (HP:0006561) | 1.71733991 |
| 145 | Acute lymphatic leukemia (HP:0006721) | 1.71600327 |
| 146 | Adenoma sebaceum (HP:0009720) | 1.71329106 |
| 147 | Angiofibromas (HP:0010615) | 1.71329106 |
| 148 | Increased nuchal translucency (HP:0010880) | 1.71252188 |
| 149 | Renal cortical cysts (HP:0000803) | 1.69417090 |
| 150 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69293279 |
| 151 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69293279 |
| 152 | Poor eye contact (HP:0000817) | 1.67602581 |
| 153 | Reduced antithrombin III activity (HP:0001976) | 1.67289847 |
| 154 | Agammaglobulinemia (HP:0004432) | 1.67218800 |
| 155 | CNS demyelination (HP:0007305) | 1.66976597 |
| 156 | Colitis (HP:0002583) | 1.66947154 |
| 157 | Combined immunodeficiency (HP:0005387) | 1.66127017 |
| 158 | Abnormality of DNA repair (HP:0003254) | 1.65686301 |
| 159 | Severe combined immunodeficiency (HP:0004430) | 1.65338940 |
| 160 | Prolonged neonatal jaundice (HP:0006579) | 1.65303471 |
| 161 | Retinal dysplasia (HP:0007973) | 1.65253296 |
| 162 | Neoplasm of the pancreas (HP:0002894) | 1.65079580 |
| 163 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.64982612 |
| 164 | Large eyes (HP:0001090) | 1.63630514 |
| 165 | Skin tags (HP:0010609) | 1.61303594 |
| 166 | Patellar aplasia (HP:0006443) | 1.60985471 |
| 167 | Hypoplasia of the thymus (HP:0000778) | 1.60796280 |
| 168 | Impaired platelet aggregation (HP:0003540) | 1.60547478 |
| 169 | Abnormal platelet function (HP:0011869) | 1.60547478 |
| 170 | Prominent metopic ridge (HP:0005487) | 1.60498454 |
| 171 | Deviation of the thumb (HP:0009603) | 1.60419777 |
| 172 | Carpal bone hypoplasia (HP:0001498) | 1.59679183 |
| 173 | Abnormality of iron homeostasis (HP:0011031) | 1.58647446 |
| 174 | Inflammation of the large intestine (HP:0002037) | 1.58324965 |
| 175 | Vertebral compression fractures (HP:0002953) | 1.57982230 |
| 176 | Increased serum lactate (HP:0002151) | 1.56020721 |
| 177 | Premature graying of hair (HP:0002216) | 1.55367233 |
| 178 | Limb-girdle muscle atrophy (HP:0003797) | 1.54145851 |
| 179 | 3-Methylglutaconic aciduria (HP:0003535) | 1.54136622 |
| 180 | Pancytopenia (HP:0001876) | 1.53539017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.02518145 |
| 2 | TAOK1 | 2.83960149 |
| 3 | VRK2 | 2.69697910 |
| 4 | FLT3 | 2.68151415 |
| 5 | MAP3K10 | 2.65352661 |
| 6 | MAP4K2 | 2.64830005 |
| 7 | MAP4K1 | 2.61511071 |
| 8 | WEE1 | 2.51818619 |
| 9 | ZAK | 2.48830705 |
| 10 | NUAK1 | 2.40939328 |
| 11 | CDC7 | 2.39705523 |
| 12 | TRIB3 | 2.35712185 |
| 13 | SCYL2 | 2.31400100 |
| 14 | PKN2 | 2.28076580 |
| 15 | EEF2K | 2.27406386 |
| 16 | TAOK3 | 2.26935654 |
| 17 | TGFBR1 | 2.22585348 |
| 18 | FGFR4 | 1.99125124 |
| 19 | PASK | 1.91699329 |
| 20 | CCNB1 | 1.90772832 |
| 21 | PNCK | 1.89053135 |
| 22 | NEK2 | 1.82716643 |
| 23 | ACVR1B | 1.82407439 |
| 24 | BCKDK | 1.82255049 |
| 25 | ERN1 | 1.77745734 |
| 26 | EIF2AK3 | 1.66149233 |
| 27 | BUB1 | 1.63314307 |
| 28 | LRRK2 | 1.61789228 |
| 29 | RPS6KB2 | 1.58687428 |
| 30 | MAP2K3 | 1.58002541 |
| 31 | JAK3 | 1.53501077 |
| 32 | TLK1 | 1.49821020 |
| 33 | KDR | 1.47613012 |
| 34 | ADRBK2 | 1.45830023 |
| 35 | BTK | 1.45495550 |
| 36 | DYRK3 | 1.44299638 |
| 37 | RPS6KA4 | 1.41755983 |
| 38 | ZAP70 | 1.40301061 |
| 39 | TBK1 | 1.39865157 |
| 40 | VRK1 | 1.38316781 |
| 41 | ATR | 1.36272654 |
| 42 | KIT | 1.33266656 |
| 43 | TYK2 | 1.32459952 |
| 44 | EIF2AK1 | 1.31359245 |
| 45 | MAP2K7 | 1.24131347 |
| 46 | PLK4 | 1.23849332 |
| 47 | CAMKK2 | 1.22271851 |
| 48 | STK10 | 1.18635258 |
| 49 | IRAK3 | 1.18482174 |
| 50 | TIE1 | 1.17587540 |
| 51 | MAP3K14 | 1.16232529 |
| 52 | AURKB | 1.14853463 |
| 53 | BRSK2 | 1.13736614 |
| 54 | MAP3K5 | 1.12319836 |
| 55 | PINK1 | 1.10070561 |
| 56 | FGR | 1.09445230 |
| 57 | ILK | 1.08733588 |
| 58 | SYK | 1.07304478 |
| 59 | TGFBR2 | 1.06861278 |
| 60 | CDK12 | 1.05941029 |
| 61 | CDK7 | 1.05807339 |
| 62 | PIM2 | 1.04132341 |
| 63 | CDK4 | 1.02673123 |
| 64 | PTK2B | 1.01439537 |
| 65 | MAPK13 | 1.00970648 |
| 66 | MAP3K4 | 0.99856782 |
| 67 | SRPK1 | 0.99780628 |
| 68 | MAP3K11 | 0.99430987 |
| 69 | MAP3K3 | 0.99141488 |
| 70 | IRAK4 | 0.98260692 |
| 71 | MATK | 0.97654111 |
| 72 | PIM1 | 0.96645627 |
| 73 | IKBKE | 0.95769936 |
| 74 | PAK4 | 0.94779445 |
| 75 | AKT3 | 0.94291373 |
| 76 | BRD4 | 0.93959786 |
| 77 | CSNK1G3 | 0.92434082 |
| 78 | TESK2 | 0.92329435 |
| 79 | FES | 0.90971726 |
| 80 | ABL2 | 0.90284944 |
| 81 | TTN | 0.89314854 |
| 82 | CSNK1A1L | 0.87805151 |
| 83 | BLK | 0.87503491 |
| 84 | ITK | 0.86757523 |
| 85 | MAPK11 | 0.84585644 |
| 86 | TNK2 | 0.84107074 |
| 87 | STK16 | 0.84058875 |
| 88 | MAP3K8 | 0.83446030 |
| 89 | CSF1R | 0.82994540 |
| 90 | STK4 | 0.81088106 |
| 91 | FRK | 0.80296272 |
| 92 | GRK6 | 0.79929186 |
| 93 | NEK1 | 0.79106776 |
| 94 | TEC | 0.76982795 |
| 95 | PDGFRA | 0.76523775 |
| 96 | MAPKAPK3 | 0.75717168 |
| 97 | MUSK | 0.75644176 |
| 98 | DAPK1 | 0.74458000 |
| 99 | DYRK1B | 0.72081898 |
| 100 | TSSK6 | 0.71369830 |
| 101 | MKNK1 | 0.69989134 |
| 102 | PLK1 | 0.69547852 |
| 103 | NEK9 | 0.68305029 |
| 104 | HIPK2 | 0.65452910 |
| 105 | YES1 | 0.63858807 |
| 106 | PTK6 | 0.63586009 |
| 107 | CSNK1G2 | 0.62568080 |
| 108 | PRPF4B | 0.62214427 |
| 109 | IKBKB | 0.62019702 |
| 110 | CHUK | 0.61708751 |
| 111 | CHEK2 | 0.60829219 |
| 112 | BMPR1B | 0.60793222 |
| 113 | DAPK2 | 0.59159185 |
| 114 | FGFR3 | 0.59087255 |
| 115 | SIK3 | 0.57640118 |
| 116 | TXK | 0.57587283 |
| 117 | CDK6 | 0.57138080 |
| 118 | CHEK1 | 0.55847266 |
| 119 | MAP2K6 | 0.55762711 |
| 120 | PRKCQ | 0.53189252 |
| 121 | TTK | 0.53057005 |
| 122 | SIK1 | 0.52374110 |
| 123 | BRAF | 0.52279020 |
| 124 | SIK2 | 0.52274253 |
| 125 | CSNK1G1 | 0.52237251 |
| 126 | INSRR | 0.51561274 |
| 127 | ICK | 0.51053886 |
| 128 | ATM | 0.49746284 |
| 129 | AKT2 | 0.49378801 |
| 130 | TAOK2 | 0.47972846 |
| 131 | NME1 | 0.47362851 |
| 132 | RIPK1 | 0.46860295 |
| 133 | LCK | 0.46670485 |
| 134 | PRKCI | 0.46504345 |
| 135 | BRSK1 | 0.45494102 |
| 136 | LYN | 0.44271439 |
| 137 | CDK19 | 0.43392045 |
| 138 | PKN1 | 0.43146896 |
| 139 | MARK3 | 0.42134836 |
| 140 | OXSR1 | 0.41918874 |
| 141 | CSNK2A2 | 0.40998840 |
| 142 | AURKA | 0.40401694 |
| 143 | MTOR | 0.40250406 |
| 144 | RPS6KA5 | 0.39853519 |
| 145 | CAMKK1 | 0.39147358 |
| 146 | UHMK1 | 0.38331042 |
| 147 | CSNK2A1 | 0.33820309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.89943131 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.09081867 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.72915887 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.24727018 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 3.23096282 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.58877676 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.50251020 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.44391998 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.39200500 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.26000524 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.24704017 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.23138638 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.20983662 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.17573488 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.08583469 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.80544757 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.79550252 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.68517425 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.59355966 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58644233 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.49733553 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45660072 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41865662 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35281367 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.35246089 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.31122698 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30692390 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28762552 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28259183 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26040046 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25564850 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23195225 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20736639 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18982706 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.18925709 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.16589513 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16402114 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11328905 |
| 39 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08883246 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.08211101 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07103871 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06489528 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06332435 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06221891 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05401859 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.03078986 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02664122 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02515502 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01655863 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00961430 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98906370 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.98387385 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94613445 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93356842 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92039515 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89488229 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84115779 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80872156 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.78985136 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.77511550 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.77499462 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.76683580 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75334869 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.74592925 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73538740 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.73435278 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72866265 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72594764 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70819477 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.70024210 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69678123 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69111469 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67793731 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67063738 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65155080 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64348148 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64097764 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.64094541 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.63920108 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63881333 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63277288 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61324031 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60374305 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59549255 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57749961 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57403583 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57299386 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56638193 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53324552 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53090096 |
| 91 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52718748 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52236293 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.51286064 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51278371 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50380492 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49989713 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49078452 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49054780 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49030935 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47284792 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45983103 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45664080 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.45524422 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44121299 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44087418 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43623186 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43568286 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.43384124 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42709992 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42352651 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42086138 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41228579 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40469261 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39819187 |
| 115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37969497 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.36352817 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35843094 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34830654 |
| 119 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33834497 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33309953 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32887112 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32436174 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32227158 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32216000 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32013805 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31227349 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30882997 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30690526 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30608926 |
| 130 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30481204 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28579264 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26383631 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25804494 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | 0.25015790 |
| 135 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24666901 |

